Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES ELDER PHARMA VENUS REMEDIES/
ELDER PHARMA
 
P/E (TTM) x 15.0 -1.0 - View Chart
P/BV x 0.9 0.1 939.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VENUS REMEDIES   ELDER PHARMA
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
ELDER PHARMA
Jun-14
VENUS REMEDIES/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs379380 99.7%   
Low Rs145188 77.1%   
Sales per share (Unadj.) Rs415.5489.2 84.9%  
Earnings per share (Unadj.) Rs19.9-3.2 -624.9%  
Cash flow per share (Unadj.) Rs44.014.4 305.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs344.3376.5 91.4%  
Shares outstanding (eoy) m13.3720.54 65.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.60.6 108.6%   
Avg P/E ratio x13.2-89.3 -14.8%  
P/CF ratio (eoy) x5.919.7 30.2%  
Price / Book Value ratio x0.80.8 100.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,5015,832 60.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5702,179 26.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,55510,048 55.3%  
Other income Rs m103257 40.2%   
Total revenues Rs m5,65810,305 54.9%   
Gross profit Rs m6022,921 20.6%  
Depreciation Rs m323361 89.4%   
Interest Rs m32,756 0.1%   
Profit before tax Rs m37960 633.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m114125 90.8%   
Profit after tax Rs m266-65 -406.8%  
Gross profit margin %10.829.1 37.3%  
Effective tax rate %30.0209.1 14.3%   
Net profit margin %4.8-0.6 -735.8%  
BALANCE SHEET DATA
Current assets Rs m3,2309,240 35.0%   
Current liabilities Rs m8269,998 8.3%   
Net working cap to sales %43.3-7.5 -573.9%  
Current ratio x3.90.9 423.2%  
Inventory Days Days37128 28.8%  
Debtors Days Days504602 83.7%  
Net fixed assets Rs m2,78113,642 20.4%   
Share capital Rs m134206 65.0%   
"Free" reserves Rs m4,4707,528 59.4%   
Net worth Rs m4,6037,733 59.5%   
Long term debt Rs m3874,889 7.9%   
Total assets Rs m6,01122,882 26.3%  
Interest coverage x130.01.0 12,725.3%   
Debt to equity ratio x0.10.6 13.3%  
Sales to assets ratio x0.90.4 210.5%   
Return on assets %4.511.8 38.0%  
Return on equity %5.8-0.8 -683.4%  
Return on capital %7.722.3 34.3%  
Exports to sales %03.1 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m0307 0.0%   
Fx outflow Rs m0125 0.0%   
Net fx Rs m0181 0.0%   
CASH FLOW
From Operations Rs m36611,754 3.1%  
From Investments Rs m-508-561 90.7%  
From Financial Activity Rs m-6-6,762 0.1%  
Net Cashflow Rs m-2205,466 -4.0%  

Share Holding

Indian Promoters % 41.8 25.3 164.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 24.0 6.6%  
FIIs % 1.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 74.7 78.0%  
Shareholders   19,560 31,548 62.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs Elder Pharma Share Price Performance

Period VENUS REMEDIES Elder Pharma S&P BSE HEALTHCARE
1-Day 7.05% 4.97% 1.18%
1-Month -4.10% 21.21% -0.75%
1-Year 103.11% -64.54% 61.82%
3-Year CAGR 4.62% -51.65% 18.16%
5-Year CAGR 58.05% -37.46% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.